Table 7.
Multivariate analysis
| Variable (examined explanatory variable) | Odds ratio | 95% CI | P value | |
|---|---|---|---|---|
| 28-day mortality (Presepsin on Day 1, Presepsin on Day 2) | ||||
| Presepsin on Day 1 | 0.9989 | 0.9974 | 1.0003 | 0.120 |
| Presepsin on Day 2 | 1.0018 | 1.0002 | 1.0034 | 0.027 |
| 28-day mortality (Presepsin on Day 1, iPS-PLR) | ||||
| Presepsin on Day 1 | 1.0004 | 0.9998 | 1.0010 | 0.182 |
| iPS-PLR | 3.1006 | 0.7548 | 12.7370 | 0.116 |
| 28-day mortality (Presepsin on Day 1, Cre on Day 1) | ||||
| Presepsin on Day 1 | 1.0006 | 1.0001 | 1.0012 | 0.028 |
| Cre on Day 1 | 0.6670 | 0.3102 | 1.4342 | 0.300 |
| 28-day mortality (Presepsin on Day 2, Cre on Day 2) | ||||
| Presepsin on Day 2 | 1.0008 | 1.0000 | 1.0015 | 0.053 |
| Cre on Day 2 | 0.5674 | 0.1051 | 3.0628 | 0.510 |
| 60-day mortality (Presepsin on Day 1, Presepsin on Day 2) | ||||
| Presepsin on Day 1 | 0.9989 | 0.9975 | 1.0003 | 0.132 |
| Presepsin on Day 2 | 1.0015 | 1.0001 | 1.0028 | 0.039 |
| 60-day mortality (Presepsin on Day 1, iPS-PLR) | ||||
| Presepsin on Day 1 | 1.0003 | 0.9998 | 1.0009 | 0.217 |
| iPS-PLR | 2.1516 | 0.5980 | 7.7414 | 0.241 |
| 60-day mortality (Presepsin on Day 1, Cre on Day 1) | ||||
| Presepsin on Day 1 | 1.0005 | 1.0000 | 1.0010 | 0.054 |
| Cre on Day 1 | 0.5945 | 0.2704 | 1.3070 | 0.196 |
| 60-day mortality (Presepsin on Day 2, Cre on Day 2) | ||||
| Presepsin on Day 2 | 1.0006 | 1.0000 | 1.0012 | 0.058 |
| Cre on Day 2 | 0.4995 | 0.1077 | 2.3167 | 0.375 |
| 90-day mortality (Presepsin on Day 1, Presepsin on Day 2) | ||||
| Presepsin on Day 1 | 0.9991 | 0.9978 | 1.0004 | 0.172 |
| Presepsin on Day 2 | 1.0011 | 0.9998 | 1.0023 | 0.086 |
| 90-day mortality (Presepsin on Day 1, Cre on Day 1) | ||||
| Presepsin on Day 1 | 1.0004 | 0.9999 | 1.0009 | 0.104 |
| Cre on Day 1 | 0.6748 | 0.3491 | 1.3044 | 0.242 |
| 90-day mortality (Presepsin on Day 2, Cre on Day 2) | ||||
| Presepsin on Day 2 | 1.0004 | 0.9999 | 1.0009 | 0.100 |
| Cre on Day 2 | 0.6546 | 0.2224 | 1.9265 | 0.442 |
| 180-day mortality (Presepsin on Day 1, Presepsin on Day 2) | ||||
| Presepsin on Day 1 | 0.9987 | 0.9972 | 1.0002 | 0.078 |
| Presepsin on Day 2 | 1.0015 | 1.0001 | 1.0029 | 0.037 |
| 180-day mortality (Presepsin on Day 1, Cre on Day 1) | ||||
| Presepsin on Day 1 | 1.0004 | 0.9999 | 1.0009 | 0.124 |
| Cre on Day 1 | 0.6812 | 0.3612 | 1.2850 | 0.236 |
| 180-day mortality (Presepsin on Day 2, Cre on Day 2) | ||||
| Presepsin on Day 2 | 1.0004 | 0.9999 | 1.0010 | 0.100 |
| Cre on Day 2 | 0.6311 | 0.2145 | 1.8566 | 0.403 |
CI confidence interval, iPS inflammation-Presepsin Score, PLR platelet to lymphocyte ratio, Cre creatinine